Medtronic PLC (NYSE: MDT) April 17, 2015 SALE av $76.49
Medtronic Inc. (Medtronic) is a medical technology company. The company offers its products to hospitals, physicians, clinicians and patients in more than 140 countries. The company operates in three segments: Cardiovascular Group Restorative Therapies Group and Diabetes Group. The Cardiovascular Group segment manufactures and markets medical therapies based on structural devices and endovascular disease Cardiac Rhythm Management (CRDM) coronary. The restorative segment manufacturing and marketing of medical therapies based therapies spinal devices and neuromodulation Surgical Technologies. Diabetes Group segment manufactures and distributes therapeutic medical devices for diabetes based. The company also offers systems Heli Heli-FX and FX-thoracic EndoAnchor that have deployed an anchor to link several endovascular aortic wall at the native vessel stenting. It also focuses on the distribution of Steerable Sheath TourGuide the US and Europe.